BNGO Bionano Genomics, Inc. - Common Stock
NASDAQ · Life Sciences Tools & Services · View on SEC EDGAR ↗ 10-K/10-Q Aug 10, 2026
$1.20
· of 52w range
· above low
· to high
$1.0052w low
$2.2352w high
Market Cap (MRQ)
$14M
P/E (TTM)
-0.4
EPS (TTM)
$-3.11
Revenue (TTM)
$30M
your badges
52W Range
$1–$2
Analyst Rating
BUY
Price Target
$5
P/E
-0.4
ROE
-83.6%
Net Profit Margin
-106.6%
Your badge strip is empty — pin a metric anywhere on this page.
BNGO Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.20
Market Cap (MRQ)
$14M
P/E (TTM)
-0.4
EPS (TTM)
$-3.11
Revenue (TTM)
$30M
ROE (TTM)
-83.6%
52W Range
$1–$2
BNGO Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Jan. 27, 2025 | 1-for-60 | Reverse |
| Aug. 7, 2023 | 1-for-10 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$29M2017-12-31 → 2025-12-31
EPS$-4.852021-12-31 → 2025-12-31
Free Cash Flow·2018-12-31 → 2020-12-31
Net margin-106.6%2018-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | BNGO | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -0.45Y avg ≈-1418.4 | ≈-1418.4 | · | · | |
| P/S (TTM) | 0.55Y avg ≈7680.7 | ≈7680.7 | 0.4 | Overvalued | |
| P/B (MRQ) | 0.45Y avg ≈528.0 | ≈528.0 | · | · | |
| Price / Cash Flow | -0.85Y avg ≈-1870.4 | ≈-1870.4 | · | · | |
| Price / Tangible Book (MRQ) | 0.55Y avg ≈823.5 | ≈823.5 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | BNGO | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | -106.7%5Y avg ≈-390.7% | ≈-390.7% | -4.8% | Weak | |
| EBITDA Margin (TTM) | -75.8%5Y avg ≈-356.6% | ≈-356.6% | -4.8% | Weak | |
| Pretax Margin (TTM) | -106.4%5Y avg ≈-400.9% | ≈-400.9% | -27.4% | Weak | |
| Net Profit Margin (TTM) | -106.6%5Y avg ≈-396.0% | ≈-396.0% | -27.0% | Weak | |
| ROA (TTM) | -52.0%5Y avg ≈-54.6% | ≈-54.6% | -44.8% | Top tier | |
| ROE (TTM) | -83.6%5Y avg ≈-122.4% | ≈-122.4% | -83.1% | Top tier | |
| ROIC | -75.2%5Y avg ≈-133.6% | ≈-133.6% | -83.1% | In line |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | BNGO | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 2.55Y avg ≈4.3 | ≈4.3 | 1.9 | Strong liquidity | |
| Quick Ratio | 0.45Y avg ≈0.5 | ≈0.5 | 0.8 | Low liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | BNGO | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | -7.4%5Y avg ≈34.8% | ≈34.8% | · | · | |
| Revenue CAGR 3Y | 0.84%5Y avg ≈27.5% | ≈27.5% | · | · | |
| Revenue CAGR 5Y | 27.4% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | BNGO | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.45Y avg ≈0.2 | ≈0.2 | 0.4 | Weak | |
| Inventory Turnover | 1.55Y avg ≈1.3 | ≈1.3 | · | · | |
| Receivables Turnover | 5.75Y avg ≈4.8 | ≈4.8 | 5.7 | In line | |
| Revenue / Employee | ≈$300.1K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
9.0%
Next Report
Nov 11, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 12, 2026 | $-0.64 | $-0.70 | 8.4% |
| March 31, 2026 | May 13, 2026 | $-0.76 | $-0.90 | 15.3% |
| Dec. 31, 2025 | $-0.03 | $-1.43 | 97.9% | |
| Sept. 30, 2025 | $-1.59 | $-1.95 | 18.4% | |
| June 30, 2025 | $-1.99 | $-2.46 | 19.2% | |
| March 31, 2025 | $-1.15 | $-3.08 | 62.7% | |
| Dec. 31, 2024 | $-15.83 | $-6.12 | -158.7% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $29M | $31M | $36M | $28M | $18M | $9M | $10M | $12M | $10M | |
| Cost of Revenue | $15M | $30M | $27M | $22M | $14M | $6M | $7M | $9M | $6M | |
| R&D Expense | $11M | $25M | $54M | $49M | $22M | $10M | $9M | $9M | $12M | |
| SG&A Expense | $35M | $52M | $93M | $89M | $58M | $31M | $20M | $14M | $14M | |
| Operating Expenses | $47M | $104M | $225M | $138M | $81M | $41M | $29M | $24M | $27M | |
| Operating Income | $-33M | $-104M | $-215M | $-132M | $-77M | $-39M | $-26M | $-20M | $-23M | |
| Interest Expense | · | · | $5M | $298.0K | $927.0K | $3M | $2M | $1M | $590.9K | |
| Interest Income | $1M | $2M | $3M | $2M | $400.0K | · | · | · | · | |
| Other Non-op | $6M | $-10M | $-20M | $-223.0K | $-59.0K | $-7.0K | $-4M | $2M | $-128.0K | |
| Pretax Income | $-26M | $-112M | $-232M | $-131M | $-78M | $-41M | $-30M | $-18M | $-23M | |
| Income Tax | $67.0K | $33.0K | $62.0K | $2M | $-6M | $29.0K | $21.0K | $15.5K | $18.6K | |
| Net Income | $-26M | $-112M | $-232M | $-133M | $-72M | $-41M | $-30M | $-18M | $-23M | |
| EPS (Basic) | $-4.85 | $-88.13 | $-408.60 | $-4.58 | $-0.26 | · | · | · | · | |
| EPS (Diluted) | $-4.85 | $-88.13 | $-408.60 | $-4.58 | $-0.26 | · | · | · | · | |
| Shares (Basic) | 5,445,000 | 1,271,000 | 569,000 | 28,921,000 | 276,782,000 | · | · | · | · | |
| Shares (Diluted) | 5,445,000 | 1,271,000 | 569,000 | 28,921,000 | 276,782,000 | · | · | · | · | |
| EBITDA | $-24M | $-90M | $-202M | $-122M | $-74M | $-37M | $-25M | $-19M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3M | $9M | $18M | $5M | $25M | $38M | $17M | $17M | $1M | |
| Receivables | $5M | $5M | $9M | $7M | $5M | $3M | $6M | $5M | $3M | |
| Inventory | $8M | $13M | $28M | $30M | $12M | $3M | $3M | $1M | $2M | |
| Prepaid Expense | $5M | $3M | $6M | $7M | $4M | $2M | $1M | $919.5K | $1M | |
| Other Current Assets | $2M | $1M | $976.0K | $2M | $1M | $462.0K | $457.1K | $384.1K | $550.1K | |
| Current Assets | $45M | $39M | $140M | $157M | $272M | $47M | $28M | $23M | $7M | |
| PP&E (Net) | $15M | $19M | $23M | $18M | $10M | $5M | $2M | $2M | $3M | |
| PP&E (Gross) | $43M | $46M | $42M | $31M | $19M | $12M | $8M | $7M | $7M | |
| Accum. Depreciation | $28M | $27M | $19M | $13M | $9M | $7M | $6M | $5M | $4M | |
| Goodwill | · | · | $0 | $77M | $56M | $7M | $0 | · | · | |
| Intangibles | $4M | $10M | $34M | $41M | $27M | $1M | $0 | · | · | |
| Other Non-current Assets | $3M | $3M | $7M | $2M | $749.0K | $103.0K | $0 | · | · | |
| Total Assets | $74M | $77M | $214M | $308M | $377M | $60M | $30M | $25M | $10M | |
| Accounts Payable | $6M | $7M | $10M | $13M | $11M | $3M | $3M | $1M | $2M | |
| Accrued Liabilities | $5M | $6M | $8M | $11M | $9M | $6M | $3M | $3M | $4M | |
| Current Liabilities | $23M | $37M | $100M | $36M | $22M | $9M | $26M | $5M | $17M | |
| Capital Leases | $2M | $145.0K | $4M | $6M | $5M | $0 | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | $0 | $44.5K | $808.4K | $567.0K | |
| Total Liabilities | $29M | $41M | $118M | $58M | $40M | $25M | $27M | $15M | $17M | |
| Long-term Debt | · | · | · | · | · | $16M | $20M | $9M | $7M | |
| Total Debt | · | · | · | · | $0 | $16M | $20M | $9M | · | |
| Common Stock | $1.0K | $0 | $0 | $3.0K | $29.0K | $19.0K | $3.4K | $1.0K | $8 | |
| Retained Earnings | $-720M | $-693M | $-581M | $-349M | $-216M | $-144M | $-103M | $-73M | $-54M | |
| AOCI | $17.0K | $27.0K | $23.0K | $-1M | $-539.0K | $0 | · | · | · | |
| Stockholders' Equity | $44M | $35M | $96M | $249M | $337M | $35M | $4M | $10M | $-50M | |
| Liabilities + Equity | $74M | $77M | $214M | $308M | $377M | $60M | $30M | $25M | $10M | |
| Shares Outstanding | 10,740,200 | 1,865,400 | 762,600 | 495,300 | 28,960,000 | 189,953,000 | 34,274,469 | 10,055,072 | 77,257 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $10M | $14M | $14M | $10M | $3M | $1M | $1M | $1M | $2M | |
| Stock-based Comp | $5M | $10M | $15M | $22M | $10M | $2M | $1M | $1M | $382.8K | |
| Deferred Tax | $0 | $0 | $0 | $2M | $-6M | $0 | · | · | · | |
| Amort. of Intangibles | $5M | $7M | $7M | $6M | $1M | $100.0K | · | · | · | |
| Restructuring | $0 | · | · | · | · | · | · | · | · | |
| Other Non-cash | $-4M | $19M | $78M | $-26M | $-7M | $-241.6K | $-2M | $-4M | · | |
| Operating Cash Flow | $-16M | $-69M | $-125M | $-125M | $-72M | $-38M | $-30M | $-20M | $-21M | |
| CapEx | · | · | · | · | · | $0 | $61.1K | $331.7K | $1M | |
| Investing Cash Flow | $-13M | $74M | $24M | $83M | $-278M | $-2M | $-61.1K | $-331.7K | $-1M | |
| Stock Issued | $31M | $44M | $58M | $23M | · | · | · | · | · | |
| Net Stock Activity | $31M | $44M | $58M | · | · | · | · | · | · | |
| Financing Cash Flow | $24M | $-14M | $114M | $23M | $336M | $62M | $30M | $36M | $18M | |
| Net Change in Cash | $-5M | $-9M | $13M | $-19M | $-14M | $21M | $788.6K | $16M | $-4M | |
| Taxes Paid | $119.0K | $54.0K | · | · | · | · | · | · | · | |
| Free Cash Flow | · | · | · | · | · | $-38M | $-30M | $-20M | · | |
| Levered FCF | · | · | · | · | · | $-41M | $-32M | $-22M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -117.0% | -337.9% | -596.0% | -473.7% | -428.8% | -453.4% | -255.4% | -170.1% | · | |
| Net Margin | -92.6% | -364.0% | -643.7% | -476.9% | -402.8% | -483.4% | -294.3% | -154.1% | · | |
| Pretax Margin | -92.3% | -363.9% | -643.6% | -470.2% | -434.6% | -483.1% | -294.1% | -154.0% | · | |
| EBITDA Margin | -83.5% | -292.3% | -558.0% | -439.1% | -410.2% | -436.0% | -244.3% | -159.1% | · | |
| ROA | -35.1% | -77.0% | -89.1% | -38.7% | -33.1% | -90.7% | -108.4% | -105.8% | · | |
| ROE | -58.8% | -265.9% | -216.1% | -49.9% | -21.3% | -165.2% | 1583.7% | -145.8% | · | |
| ROIC | -75.2% | -294.0% | -223.9% | -53.6% | -21.2% | -75.0% | -109.3% | -106.6% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 1.1 | 1.4 | 4.4 | 12.5 | 5.2 | 1.1 | 5.1 | · | |
| Quick Ratio | 0.4 | 0.4 | 0.3 | 0.3 | 1.4 | 4.6 | 0.9 | 4.7 | · | |
| Debt / Equity | · | · | · | · | 0.0 | 0.5 | 5.6 | 0.9 | · | |
| LT Debt / Equity | · | · | · | · | 0.0 | 0.5 | 0.0 | 0.9 | · | |
| Interest Coverage | · | · | -42.0 | -441.9 | -83.2 | -15.3 | -11.3 | -14.8 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.2 | 0.1 | 0.1 | 0.1 | 0.2 | 0.4 | 0.7 | · | |
| Inventory Turnover | 1.5 | 1.5 | 0.9 | 1.0 | 1.8 | 1.7 | 3.0 | 6.3 | · | |
| Receivables Turnover | 5.7 | 4.4 | 4.4 | 4.7 | 4.7 | 1.9 | 1.9 | 3.1 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.14 | $18.96 | $2.10 | $0.84 | $1.16 | $0.18 | $0.11 | $1.01 | · | |
| Revenue / Share | $5.24 | $24.21 | $1.06 | $0.10 | · | · | · | · | · | |
| Cash Flow / Share | $-3.00 | $-54.23 | $-3.67 | $-0.43 | · | · | · | · | · | |
| Cash / Share | $0.28 | $4.92 | $0.39 | $0.02 | $0.08 | $0.20 | $0.51 | $1.64 | · | |
| EPS (TTM) | $-4.85 | $-88.13 | $-408.60 | $-4.58 | $-0.26 | · | · | · | · |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -7.4% | -14.8% | 29.9% | 54.6% | 111.5% | · | · | · | · | |
| Revenue CAGR 3Y | 0.84% | 19.6% | 62.0% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 27.4% | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $29M | $31M | $36M | $28M | $18M | $9M | $10M | $12M | · | |
| Net Income TTM | $-26M | $-112M | $-232M | $-133M | $-72M | $-41M | $-30M | $-18M | · | |
| Market Cap | $16M | $32M | $5.19B | $260.33B | $519.55B | $351.03B | $25.50B | $31.61B | · | |
| Enterprise Value | · | · | · | · | $519.52B | $351.01B | $25.50B | $31.61B | · | |
| P/E | -0.3 | -0.2 | -0.3 | -191.3 | -6900.0 | · | · | · | · | |
| P/S | 0.6 | 1.1 | 143.7 | 9363.8 | 28894.2 | 41283.4 | 2517.4 | 2634.3 | · | |
| P/B | 0.4 | 0.9 | 54.0 | 1043.8 | 1541.1 | 10006.0 | 7056.5 | 3118.5 | · | |
| P / Tangible Book | 0.4 | 1.3 | 83.4 | 1987.8 | 2044.5 | 13279.6 | · | · | · | |
| P / Cash Flow | -1.0 | -0.5 | -41.4 | -2085.7 | -7223.2 | -9161.9 | -863.5 | -1585.1 | · | |
| P / FCF | · | · | · | · | · | -9161.9 | -861.8 | -1559.2 | · | |
| EV / EBITDA | · | · | · | · | -7044.4 | -9468.4 | -1030.5 | -1655.2 | · | |
| EV / FCF | · | · | · | · | · | -9161.3 | -861.9 | -1558.8 | · | |
| EV / Revenue | · | · | · | · | 28892.8 | 41280.8 | 2517.7 | 2633.6 | · | |
| Earnings Yield | -317.0% | -506.5% | -360.3% | -0.52% | -0.01% | · | · | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8M | $7M | $8M | $7M | $7M | $6M | $8M | $6M | $8M | $9M | $11M | $9M | $9M | $7M | $8M | $7M | |
| Cost of Revenue | $4M | $3M | $5M | $4M | $3M | $4M | $5M | $15M | $5M | $6M | $8M | $7M | $6M | $5M | $6M | $5M | |
| R&D Expense | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $5M | $7M | $10M | $12M | $14M | $15M | $14M | $14M | $13M | |
| SG&A Expense | $9M | $8M | $9M | $9M | $8M | $9M | $12M | $9M | $12M | $19M | $15M | $25M | $27M | $26M | $25M | $21M | |
| Operating Expenses | $12M | $11M | $12M | $12M | $11M | $11M | $15M | $35M | $20M | $34M | $27M | $116M | $42M | $40M | $39M | $34M | |
| Operating Income | $-7M | $-8M | $-9M | $-9M | $-8M | $-8M | $-12M | $-44M | $-17M | $-31M | $-25M | $-113M | $-39M | $-38M | $-38M | $-32M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $122.0K | · | $71.0K | $74.0K | $76.0K | $74.0K | $73.0K | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $800.0K | $400.0K | |
| Other Non-op | $-344.0K | $-619.0K | $363.0K | $-219.0K | $676.0K | $5M | $-8M | $-697.0K | $363.0K | $-1M | $-20M | $-45.0K | $-330.0K | $117.0K | $-39.0K | $5.0K | |
| Pretax Income | $-7M | $-8M | $-8M | $-8M | $-7M | $-3M | $-20M | $-44M | $-16M | $-31M | $-44M | $-113M | $-39M | $-37M | $-37M | $-32M | |
| Income Tax | $7.0K | $10.0K | $36.0K | $14.0K | $10.0K | $7.0K | $1.0K | $24.0K | $26.0K | $-18.0K | $-36.0K | $39.0K | $33.0K | $26.0K | $2M | $28.0K | |
| Net Income | $-7M | $-8M | $-8M | $-9M | $-7M | $-3M | $-20M | $-44M | $-16M | $-31M | $-44M | $-113M | $-39M | $-37M | $-39M | $-32M | |
| EPS (Basic) | $-0.64 | $-0.76 | $-0.12 | $-1.59 | $-1.99 | $-1.15 | $-7.05 | $-30.92 | $-14.41 | $-35.75 | $-402.91 | $-3.22 | $-1.24 | $-1.23 | $-2.24 | $-1.10 | |
| EPS (Diluted) | $-0.64 | $-0.76 | $-0.12 | $-1.59 | $-1.99 | $-1.15 | $-7.05 | $-30.92 | $-14.41 | $-35.75 | $-402.91 | $-3.22 | $-1.24 | $-1.23 | $-2.24 | $-1.10 | |
| Shares (Basic) | 11,546,000 | 10,979,000 | · | 5,338,000 | 3,441,000 | 2,694,000 | · | 1,431,000 | 1,126,000 | 879,000 | · | 35,001,000 | 31,498,000 | 30,205,000 | · | 28,970,000 | |
| Shares (Diluted) | 11,546,000 | 10,979,000 | · | 5,338,000 | 3,441,000 | 2,694,000 | · | 1,431,000 | 1,126,000 | 879,000 | · | 35,001,000 | 31,498,000 | 30,205,000 | · | 28,970,000 | |
| EBITDA | $-7M | $-6M | · | $-9M | $-8M | $-6M | · | $-44M | $-17M | $-28M | · | $-113M | $-39M | $-35M | · | $-32M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $3M | $3M | $3M | $4M | $4M | $9M | $9M | $10M | $16M | $18M | $35M | $15M | $4M | $5M | $28M | |
| Receivables | $4M | $4M | $5M | $5M | $3M | $3M | $5M | $5M | $6M | $8M | $9M | $9M | $8M | $7M | $7M | $6M | |
| Inventory | $7M | $8M | $8M | $8M | $10M | $11M | $13M | $16M | $23M | $24M | $28M | $34M | $32M | $33M | $30M | $25M | |
| Prepaid Expense | $5M | $5M | $5M | $5M | $3M | $3M | $3M | $4M | $5M | $5M | $6M | $6M | $5M | $7M | $7M | $7M | |
| Other Current Assets | · | · | $2M | · | · | · | $1M | · | · | · | $976.0K | · | · | · | $2M | · | |
| Current Assets | $25M | $39M | $45M | $49M | $43M | $45M | $39M | $47M | $61M | $86M | $140M | $105M | $123M | $143M | $157M | $218M | |
| PP&E (Net) | $13M | $14M | $15M | $16M | $17M | $18M | $19M | $20M | $25M | $25M | $23M | $21M | $20M | $19M | $18M | $16M | |
| PP&E (Gross) | $42M | $43M | $43M | · | · | · | $46M | · | · | · | $42M | · | · | · | $31M | · | |
| Accum. Depreciation | $29M | $29M | $28M | · | · | · | $27M | · | · | · | $19M | · | · | · | $13M | · | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $77M | $77M | $77M | $56M | |
| Intangibles | $2M | $3M | $4M | $6M | $7M | $8M | $10M | $11M | $30M | $32M | $34M | $36M | $38M | $39M | $41M | $23M | |
| Other Non-current Assets | $2M | $3M | $3M | $2M | $2M | $2M | $3M | $3M | $6M | $7M | $7M | $10M | $3M | $3M | $2M | $802.0K | |
| Total Assets | $48M | $65M | $74M | $79M | $76M | $78M | $77M | $87M | $129M | $158M | $214M | $182M | $271M | $292M | $308M | $324M | |
| Accounts Payable | $5M | $5M | $6M | $6M | $6M | $7M | $7M | $9M | $9M | $10M | $10M | $15M | $12M | $16M | $13M | $9M | |
| Accrued Liabilities | $3M | $4M | $5M | $5M | $3M | $4M | $6M | $6M | $6M | $11M | $8M | $12M | $8M | $9M | $11M | $12M | |
| Current Liabilities | $10M | $21M | $23M | $23M | $24M | $26M | $37M | $33M | $37M | $59M | $100M | $40M | $33M | $38M | $36M | $34M | |
| Capital Leases | $2M | $3M | $2M | $3M | $3M | $0 | $145.0K | $2M | $2M | $3M | $4M | $4M | $5M | $5M | $6M | $5M | |
| Total Liabilities | $16M | $27M | $29M | $29M | $31M | $30M | $41M | $38M | $49M | $75M | $118M | $63M | $57M | $61M | $58M | $42M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $0 | $0 | $0 | $9.0K | $7.0K | $6.0K | $0 | $3.0K | $3.0K | $31.0K | $3.0K | $30.0K | |
| Retained Earnings | $-735M | $-728M | $-720M | $-712M | $-703M | $-696M | $-693M | $-673M | $-629M | $-613M | $-581M | $-537M | $-425M | $-386M | $-349M | $-310M | |
| AOCI | $14.0K | $12.0K | $17.0K | $6.0K | $-10.0K | $14.0K | $27.0K | $2M | $-3.0K | $-16.0K | $23.0K | $-93.0K | $-310.0K | $-665.0K | $-1M | $-2M | |
| Stockholders' Equity | $32M | $37M | $44M | $50M | $45M | $48M | $35M | $49M | $80M | $83M | $96M | $119M | $215M | $231M | $249M | $282M | |
| Liabilities + Equity | $48M | $65M | $74M | $79M | $76M | $78M | $77M | $87M | $129M | $158M | $214M | $182M | $271M | $292M | $308M | $324M | |
| Shares Outstanding | 11,777,300 | 11,276,500 | 10,740,200 | 9,730,400 | 3,909,400 | 3,101,400 | 1,865,400 | 88,468,000 | 70,776,000 | 57,539,000 | 762,533 | 35,349,000 | 33,240,000 | 306,790,000 | 29,718,000 | 296,900,000 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $6M | $3M | $3M | $4M | $4M | $3M | $3M | $3M | $2M | |
| Stock-based Comp | $970.0K | $670.0K | $926.0K | $941.0K | $1M | $2M | $2M | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $6M | |
| Other Non-cash | · | $-393.0K | · | · | · | $-4M | · | · | · | $-3M | · | · | · | $-2M | · | · | |
| Operating Cash Flow | $-5M | $-6M | $-4M | $-6M | $-3M | $-3M | $-7M | $-13M | $-21M | $-28M | $-30M | $-26M | $-37M | $-32M | $-35M | $-29M | |
| Investing Cash Flow | $14M | $5M | $4M | $-5M | $2M | $-14M | $3M | $-5M | $29M | $48M | $-55M | $33M | $30M | $17M | $12M | $8M | |
| Stock Issued | $620.0K | $705.0K | $2M | $13M | $3M | $13M | $7M | $10M | $12M | $15M | $11M | $13M | $18M | $15M | $0 | $23M | |
| Net Stock Activity | · | $705.0K | · | · | · | $13M | · | · | · | $15M | · | · | · | $15M | · | · | |
| Financing Cash Flow | $-10M | $657.0K | $2M | $10M | $1M | $11M | $4M | $6M | $-2M | $-22M | $68M | $13M | $18M | $15M | $146.0K | $23M | |
| Net Change in Cash | $-681.0K | $403.0K | $1M | $-497.0K | $-63.0K | $-6M | $379.0K | $-13M | $6M | $-2M | $-17M | $20M | $11M | $-987.0K | $-23M | $1M |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -88.3% | -118.1% | · | -115.9% | -115.9% | -131.1% | · | -722.9% | -219.0% | -354.9% | · | -1215.0% | -453.0% | -510.4% | · | -445.2% | |
| Net Margin | -90.8% | -124.2% | · | -115.4% | -101.8% | -48.0% | · | -728.6% | -208.8% | -358.3% | · | -1208.1% | -449.2% | -500.7% | · | -440.5% | |
| Pretax Margin | -90.8% | -124.0% | · | -115.2% | -101.7% | -47.9% | · | -728.2% | -208.4% | -358.5% | · | -1207.6% | -448.9% | -500.3% | · | -440.1% | |
| EBITDA Margin | -88.3% | -83.5% | · | -115.9% | -115.9% | -93.4% | · | -722.9% | -219.0% | -320.6% | · | -1215.0% | -453.0% | -467.3% | · | -445.2% | |
| ROA | -12.0% | -11.6% | · | -10.2% | -6.7% | -2.6% | · | -32.9% | -8.1% | -14.0% | · | -44.5% | -13.1% | -11.6% | · | -9.3% | |
| ROE | -19.3% | -19.4% | · | -17.2% | -10.9% | -4.7% | · | -52.7% | -11.0% | -20.0% | · | -56.2% | -15.6% | -13.7% | · | -10.2% | |
| ROIC | -22.9% | -21.1% | · | -17.2% | -17.2% | -17.6% | · | -89.9% | -21.2% | -37.6% | · | -95.2% | -18.3% | -16.4% | · | -11.4% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.5 | 1.8 | · | 2.1 | 1.8 | 1.7 | · | 1.4 | 1.6 | 1.5 | · | 2.6 | 3.7 | 3.7 | · | 6.5 | |
| Quick Ratio | 0.8 | 0.4 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 1.1 | 0.7 | 0.3 | · | 1.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -255.1 | · | -1594.5 | -530.2 | -497.9 | · | -440.4 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.4 | 0.4 | · | 0.3 | 0.2 | 0.2 | · | 0.6 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | |
| Receivables Turnover | 2.1 | 1.8 | · | 1.5 | 1.4 | 1.1 | · | 0.9 | 1.1 | 1.2 | · | 1.3 | 1.4 | 1.2 | · | 1.6 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.68 | $3.32 | · | $5.12 | $11.61 | $15.54 | · | $0.55 | $1.14 | $1.44 | · | $3.37 | $6.46 | $0.75 | · | $0.95 | |
| Revenue / Share | $0.71 | $0.61 | · | $1.38 | $1.96 | $2.40 | · | $0.07 | $0.12 | $0.17 | · | $0.27 | $0.28 | $0.02 | · | $0.02 | |
| Cash Flow / Share | · | $-0.52 | · | · | · | $-1.03 | · | · | · | $-0.53 | · | · | · | $-0.11 | · | · | |
| Cash / Share | $0.32 | $0.30 | · | $0.32 | $0.91 | $1.17 | · | $0.10 | $0.15 | $0.27 | · | $0.98 | $0.45 | $0.01 | · | $0.09 | |
| EPS (TTM) | $-3.11 | $-4.46 | · | $-11.78 | $-41.11 | $-53.53 | · | $-483.99 | $-456.29 | $-443.12 | · | $-7.93 | $-5.81 | $-5.70 | · | $-2.42 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $30M | $29M | · | $29M | $27M | $28M | · | $33M | $37M | $37M | · | $34M | $32M | $30M | · | $26M | |
| Net Income TTM | $-32M | $-32M | · | $-39M | $-74M | $-84M | · | $-136M | $-204M | $-227M | · | $-227M | $-147M | $-140M | · | $-117M | |
| Market Cap | $13M | $13M | · | $17M | $13M | $9M | · | $2.39B | $2.89B | $3.83B | · | $6.43B | $12.17B | $204.32B | · | $326.00B | |
| P/E | -0.4 | -0.3 | · | -0.1 | -0.1 | -0.1 | · | -0.1 | -0.1 | -0.2 | · | -22.9 | -63.0 | -116.8 | · | -453.7 | |
| P/S | 0.4 | 0.5 | · | 0.6 | 0.5 | 0.3 | · | 71.7 | 78.9 | 102.3 | · | 191.2 | 386.1 | 6921.2 | · | 12592.1 | |
| P/B | 0.4 | 0.4 | · | 0.3 | 0.3 | 0.2 | · | 48.9 | 35.9 | 46.3 | · | 54.0 | 56.6 | 882.7 | · | 1157.1 | |
| P / Tangible Book | 0.4 | 0.4 | · | 0.4 | 0.3 | 0.2 | · | 63.2 | 57.4 | 75.1 | · | 77.2 | 121.8 | 1779.1 | · | 1608.3 | |
| P / Cash Flow | · | -2.3 | · | · | · | -3.1 | · | · | · | -136.2 | · | · | · | -6303.7 | · | · | |
| Earnings Yield | -275.2% | -381.2% | · | -688.9% | -1253.3% | -1918.6% | · | -1792.6% | -1118.4% | -665.4% | · | -4.4% | -1.6% | -0.86% | · | -0.22% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $29M | $31M | $36M | $28M | $18M |
| Operating Margin % | -117.0% | -337.9% | -596.0% | -473.7% | -428.8% |
| Net Income | $-26M | $-112M | $-232M | $-133M | $-72M |
| Diluted EPS | $-4.85 | $-88.13 | $-408.60 | $-4.58 | $-0.26 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | · | · | · | · | 0.0 |
| Current Ratio | 2.0 | 1.1 | 1.4 | 4.4 | 12.5 |
| Quick Ratio | 0.4 | 0.4 | 0.3 | 0.3 | 1.4 |
No data for this statement
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 35 filers · $745K total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
35
Value held
$745K
New positions
8
Exited positions
7
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 8 (-2 vs prior Q) | 7 (0 vs prior Q) | 11 (+2 vs prior Q) | 2 (-2 vs prior Q) | -171K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| CARRET ASSET MANAGEMENT, LLC | $141,250 | 125,000 | 18.96% | Shares |
| VANGUARD GROUP INC | $125,930 | 82,307 | 16.91% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $101,693 | 89,993 | 13.65% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $93,098 | 82,388 | 12.50% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $58,283 | 51,578 | 7.82% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $57,743 | 51,100 | 7.75% | Shares |
| JANE STREET GROUP, LLC | $40,373 | 35,728 | 5.42% | Shares |
| PRUDENTIAL FINANCIAL INC | $35,708 | 31,600 | 4.79% | Shares |
| NORTHERN TRUST CORP | $27,754 | 24,561 | 3.73% | Shares |
| XTX Topco Ltd | $18,413 | 16,295 | 2.47% | Shares |
| Engineers Gate Manager LP | $13,546 | 11,988 | 1.82% | Shares |
| BlackRock, Inc. | $11,229 | 9,937 | 1.51% | Shares |
| OSAIC HOLDINGS, INC. | $8,819 | 7,809 | 1.18% | Shares |
| Tower Research Capital LLC (TRC) | $5,908 | 5,228 | 0.79% | Shares |
| MORGAN STANLEY | $1,172 | 1,037 | 0.16% | Shares |
| Concord Wealth Partners | $1,130 | 1,000 | 0.15% | Shares |
| GROUP ONE TRADING LLC | $1,081 | 957 | 0.15% | Shares |
| UBS Group AG | $918 | 812 | 0.12% | Shares |
| SBI Securities Co., Ltd. | $426 | 273 | 0.06% | Shares |
| GSA CAPITAL PARTNERS LLP | $170 | 150,284 | 0.02% | Shares |
| WELLS FARGO & COMPANY/MN | $128 | 113 | 0.02% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $15 | 13 | 0.00% | Shares |
| JPMORGAN CHASE & CO | $13 | 11 | 0.00% | Shares |
| HRT FINANCIAL LP | $13 | 11,740 | 0.00% | Shares |
| TD Waterhouse Canada Inc. | $8 | 5 | 0.00% | Shares |
| Caitong International Asset Management Co., Ltd | $6 | 5 | 0.00% | Shares |
| Activest Wealth Management | $5 | 3 | 0.00% | Shares |
| AllSquare Wealth Management LLC | $5 | 3 | 0.00% | Shares |
| BARCLAYS PLC | $3 | 3 | 0.00% | Shares |
| CITIGROUP INC | $3 | 3 | 0.00% | Shares |
| NATIONAL BANK OF CANADA /FI/ | $2 | 2 | 0.00% | Shares |
| Rockefeller Capital Management L.P. | $1 | 1 | 0.00% | Shares |
| Medallion Wealth Advisors, LLC | $1 | 1 | 0.00% | Shares |
| Atlantic Union Bankshares Corp | $1 | 1 | 0.00% | Shares |
| ROYAL BANK OF CANADA | $0 | 11 | 0.00% | Shares |
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Innovatus Life Sciences GP, LP, Innovatus Life Sciences Lending Fund I, LP, Innovatus Capital Partners, LLC, Innovatus Life Sciences Offshore GP, LP, Innovatus Life Sciences Offshore Fund I-A, LP ×3 filings | Nov. 13, 2019 | · | Initial filing | · | SEC |
| LC Fund VI, L.P. (2), LC Parallel Fund VI, L.P. (2), LC Healthcare Fund I, L.P. (2), Rosy Shine Limited (2), Legend Holdings (2), Legend Capital (2), Junfeng Wang (2), Quan Zhou (2), Linan Zhu (2), Hao Chen (2), Nengguang Wang (2) | June 7, 2019 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 26 insiders · 16 officers · 11 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Erik R. Holmlin | PRESIDENT AND CEO | Feb. 17, 2026 F | 1,657 | 0 | 0 | $0 |
| Gulsen Kama | Chief Financial Officer | June 3, 2024 A | 16,000 | 0 | 0 | $0 |
| Christopher P. Stewart | Chief Financial Officer | May 12, 2023 P | 281,373 | 0 | 0 | $0 |
| Michael James Ward | Former Chief Financial Officer | March 1, 2019 A | · | 0 | 0 | $0 |
| Mark Borodkin | Chief Operating Officer | Aug. 3, 2026 A | 868 | 0 | 0 | $0 |
| Albert Luderer | Interim Chief Executive | Sept. 4, 2026 P | 8,000 | 2 | 0 | $9,720 |
| Alex Reid Hastie | Chief Scientific Officer | Aug. 3, 2026 A | · | 0 | 0 | $0 |
| Mark Adamchak | Principal Accounting Officer | Aug. 3, 2026 A | 253 | 0 | 0 | $0 |
| Jonathan V. Dixon | General Counsel | Aug. 3, 2026 A | 239 | 0 | 0 | $0 |
| Alka Chaubey | CHIEF MEDICAL OFFICER | June 3, 2026 F | 620 | 0 | 0 | $0 |
| Soheil Shams | Chief Informatics Officer | Feb. 15, 2022 A | 5,325,378 | 0 | 0 | $0 |
| Richard Shippy | Chief Business Officer | Feb. 15, 2022 A | · | 0 | 0 | $0 |
| Robert J Priar | Chief Commercial Officer | June 1, 2021 A | · | 0 | 0 | $0 |
| Heather Adams | Chief Administrative Officer | Feb. 18, 2020 A | · | 0 | 0 | $0 |
| Warren Robinson | Chief Commercial Officer | March 1, 2019 A | · | 0 | 0 | $0 |
| Han Cao PHD | Chief Scientific Officer | Oct. 1, 2018 A | 112,936 | 0 | 0 | $0 |
| Aleksandar Rajkovic | Director | May 14, 2026 A | · | 0 | 0 | $0 |
| Yvonne Linney | Director | May 14, 2026 A | 0 | 0 | 0 | $0 |
| Kristiina Vuori MD | Director | May 14, 2026 A | · | 0 | 0 | $0 |
| David L Barker | Director | May 14, 2026 A | 58,364 | 0 | 0 | $0 |
| Hannah Mamuszka | Director | June 11, 2025 A | 65,789 | 0 | 0 | $0 |
| Vincent Jung-Fai Wong | Director | June 18, 2024 A | · | 0 | 0 | $0 |
| Junfeng Wang | Director | June 6, 2019 A | 2,906,915 | 0 | 0 | $0 |
| Quan Zhou | Director | June 6, 2019 A | 2,906,915 | 0 | 0 | $0 |
| Darren Cai | Director | June 6, 2019 A | · | 0 | 0 | $0 |
| Christopher J Twomey | · | May 14, 2026 A | 64,500 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 1 ETF
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0.00% | 82,388 SH | Aug. 19, 2026 | Daily |
BNGO Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 8 analysts
BUY
Median target
$5.00
+316.7%
2 25.0%
Strong Buy
5 62.5%
Buy
1 12.5%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
2 analysts · 2026-10-25Mean target $5.00 +316.7%
← Below all targets
Current price $1.20
Low$4.00
Mean$5.00
High$6.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 10, 2026